Literature DB >> 15742797

Acute stress disorder symptoms in gunshot-injured youth.

Vanya Hamrin1, Barbara Jonker, Lawrence Scahill.   

Abstract

PROBLEM: The prevalence of acute stress disorder symptoms (ASDS) and other psychiatric comorbidities in youth with recent gunshot injuries.
METHODS: Children (n=20) admitted to an urban hospital ER for gunshot injuries over a 4-year period were evaluated for ASDS, co-morbid DSM-III-R diagnoses, legal and gang involvement, and psychiatric history; medically hospitalized children (n=36) similar in age, sex, race, and socioeconomic status served as a control group.
FINDINGS: Gunshot-injured youth reported a 75% rate of ASDS compared to a 14% rate in medically ill youth (OR 18.6; chi2 = p < .0001). Parent ratings of ASDS closely corresponded with youth ratings. Youth rated reexperiencing the event as the most frequent distressing symptom. Gunshot injury was associated with legal problems, gang involvement, marijuana/alcohol dependence, conduct disorder, social phobia, and agoraphobia compared to youth with medical illness.
CONCLUSIONS: Compared to youth with medical illness, gunshot-injured youth were 18.6 times (p = .0001) more likely to show symptoms of ASDS. Further research, developmentally appropriate assessment, prevention, and treatment are needed in this area.

Entities:  

Mesh:

Year:  2004        PMID: 15742797     DOI: 10.1111/j.1744-6171.2004.tb00013.x

Source DB:  PubMed          Journal:  J Child Adolesc Psychiatr Nurs        ISSN: 1073-6077


  2 in total

Review 1.  What are the long-term consequences of youth exposure to firearm injury, and how do we prevent them? A scoping review.

Authors:  Megan Ranney; Rebecca Karb; Peter Ehrlich; Kira Bromwich; Rebecca Cunningham; Rinad S Beidas
Journal:  J Behav Med       Date:  2019-08-01

2.  The Youth Nonfatal Violent Injury Review Panel: An Innovative Model to Inform Policy and Systems Change.

Authors:  Jonathan Purtle; Linda J Rich; John A Rich; Jazzmin Cooper; Erica J Harris; Theodore J Corbin
Journal:  Public Health Rep       Date:  2015 Nov-Dec       Impact factor: 2.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.